YIL-781 | CAS# 875258-85-8 | GHS-R1a biased ligand

MedKoo Cat#: 465820 | Name: YIL-781

Description:

WARNING: This product is for research use only, not for human or veterinary use.

YIL-781 is a GHS-R1a biased ligand.

Chemical Structure

YIL-781

CAS# 875258-85-8 (free base)

Theoretical Analysis

MedKoo Cat#: 465820

Name: YIL-781

CAS#: 875258-85-8 (free base)

Chemical Formula: C24H28FN3O2

Exact Mass: 409.2166

Molecular Weight: 409.51

Elemental Analysis: C, 70.39; H, 6.89; F, 4.64; N, 10.26; O, 7.81

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

875258-85-8 (free base) 1640226-17-0 (HCl)

Synonym

YIL-781; YIL-781; YIL-781;

IUPAC/Chemical Name

(S)-6-(4-fluorophenoxy)-3-((1-isopropylpiperidin-3-yl)methyl)-2-methylquinazolin-4(3H)-one

InChi Key

FRKXOBMDEXCHHD-SFHVURJKSA-N

InChi Code

InChI=1S/C24H28FN3O2/c1-16(2)27-12-4-5-18(14-27)15-28-17(3)26-23-11-10-21(13-22(23)24(28)29)30-20-8-6-19(25)7-9-20/h6-11,13,16,18H,4-5,12,14-15H2,1-3H3/t18-/m0/s1

SMILES Code

CC(C)N1C[C@@H](CN2C(C)=NC(C=CC(OC3=CC=C(F)C=C3)=C4)=C4C2=O)CCC1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 409.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Perdonà E, Faggioni F, Buson A, Sabbatini FM, Corti C, Corsi M. Pharmacological characterization of the ghrelin receptor antagonist, GSK1614343 in rat RC-4B/C cells natively expressing GHS type 1a receptors. Eur J Pharmacol. 2011 Jan 10;650(1):178-83. doi: 10.1016/j.ejphar.2010.10.042. Epub 2010 Oct 29. PMID: 21034740. 2: Gu M, Liu C, Yang T, Zhan M, Cai Z, Chen Y, Chen Q, Wang Z. High-Fat Diet Induced Gut Microbiota Alterations Associating With Ghrelin/Jak2/Stat3 Up- Regulation to Promote Benign Prostatic Hyperplasia Development. Front Cell Dev Biol. 2021 Jun 24;9:615928. doi: 10.3389/fcell.2021.615928. PMID: 34249898; PMCID: PMC8264431. 3: Aguinaga D, Medrano M, Cordomí A, Jiménez-Rosés M, Angelats E, Casanovas M, Vega-Quiroga I, Canela EI, Petrovic M, Gysling K, Pardo L, Franco R, Navarro G. Cocaine Blocks Effects of Hunger Hormone, Ghrelin, Via Interaction with Neuronal Sigma-1 Receptors. Mol Neurobiol. 2019 Feb;56(2):1196-1210. doi: 10.1007/s12035-018-1140-7. Epub 2018 Jun 7. PMID: 29876881. 4: Furness JB, Pustovit RV, Syder AJ, Ringuet MT, Yoo EJ, Fanjul A, Wykosky J, Fothergill LJ, Whitfield EA, Furness SGB. Dopamine and ghrelin receptor co- expression and interaction in the spinal defecation centers. Neurogastroenterol Motil. 2021 May;33(5):e14051. doi: 10.1111/nmo.14051. Epub 2020 Dec 2. PMID: 33264473. 5: Broad J, Callaghan B, Sanger GJ, Brock JA, Furness JB. Analysis of the ghrelin receptor-independent vascular actions of ulimorelin. Eur J Pharmacol. 2015 Apr 5;752:34-9. doi: 10.1016/j.ejphar.2015.02.005. Epub 2015 Feb 14. PMID: 25687251. 6: Al-Ayed MSZ. Relaxant effect of ghrelin on guinea pig isolated tracheal smooth muscle: role of epithelial NO and PGE2. Pflugers Arch. 2018 Jun;470(6):949-958. doi: 10.1007/s00424-018-2126-z. Epub 2018 Feb 26. PMID: 29480331. 7: Toth K, Slosky LM, Pack TF, Urs NM, Boone P, Mao L, Abraham D, Caron MG, Barak LS. Ghrelin receptor antagonism of hyperlocomotion in cocaine-sensitized mice requires βarrestin-2. Synapse. 2018 Jan;72(1):10.1002/syn.22012. doi: 10.1002/syn.22012. Epub 2017 Oct 7. PMID: 28941296; PMCID: PMC5705267. 8: Danila GM, Puiu M, Zamfir LG, Bala C. Early Detection of Growth Hormone Secretagogue Receptor Antagonists Exploiting Their Atypical Behavior in Competitive Assays. Anal Chem. 2019 Dec 3;91(23):14812-14817. doi: 10.1021/acs.analchem.9b03845. Epub 2019 Nov 14. PMID: 31702907. 9: Yu AP, Pei XM, Sin TK, Yip SP, Yung BY, Chan LW, Wong CS, Siu PM. [D-Lys3]-GHRP-6 exhibits pro-autophagic effects on skeletal muscle. Mol Cell Endocrinol. 2015 Feb 5;401:155-64. doi: 10.1016/j.mce.2014.09.031. Epub 2014 Oct 29. PMID: 25450862. 10: Ku JM, Andrews ZB, Barsby T, Reichenbach A, Lemus MB, Drummond GR, Sleeman MW, Spencer SJ, Sobey CG, Miller AA. Ghrelin-related peptides exert protective effects in the cerebral circulation of male mice through a nonclassical ghrelin receptor(s). Endocrinology. 2015 Jan;156(1):280-90. doi: 10.1210/en.2014-1415. PMID: 25322462; PMCID: PMC4272401. 11: Mende F, Hundahl C, Plouffe B, Skov LJ, Sivertsen B, Madsen AN, Lückmann M, Diep TA, Offermanns S, Frimurer TM, Bouvier M, Holst B. Translating biased signaling in the ghrelin receptor system into differential in vivo functions. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10255-E10264. doi: 10.1073/pnas.1804003115. Epub 2018 Oct 9. PMID: 30301804; PMCID: PMC6205473. 12: Buckinx A, Van Den Herrewegen Y, Pierre A, Cottone E, Ben Haj Salah K, Fehrentz JA, Kooijman R, De Bundel D, Smolders I. Differential Effects of a Full and Biased Ghrelin Receptor Agonist in a Mouse Kindling Model. Int J Mol Sci. 2019 May 20;20(10):2480. doi: 10.3390/ijms20102480. PMID: 31137460; PMCID: PMC6567032. 13: Lin D, Wang Q, Ran H, Liu K, Wang Y, Wang J, Liu Y, Chen R, Sun Y, Liu R, Ding F. Abnormal response to the anorexic effect of GHS-R inhibitors and exenatide in male Snord116 deletion mouse model for Prader-Willi syndrome. Endocrinology. 2014 Jul;155(7):2355-62. doi: 10.1210/en.2013-2083. Epub 2014 Apr 15. PMID: 24735326. 14: Sim YB, Park SH, Kim SS, Kim CH, Kim SJ, Lim SM, Jung JS, Suh HW. Ghrelin administered spinally increases the blood glucose level in mice. Peptides. 2014 Apr;54:162-5. doi: 10.1016/j.peptides.2014.01.015. Epub 2014 Jan 25. PMID: 24472858. 15: Pustovit RV, Callaghan B, Ringuet MT, Kerr NF, Hunne B, Smyth IM, Pietra C, Furness JB. Evidence that central pathways that mediate defecation utilize ghrelin receptors but do not require endogenous ghrelin. Physiol Rep. 2017 Aug;5(15):e13385. doi: 10.14814/phy2.13385. PMID: 28801520; PMCID: PMC5555902. 16: Esler WP, Rudolph J, Claus TH, Tang W, Barucci N, Brown SE, Bullock W, Daly M, Decarr L, Li Y, Milardo L, Molstad D, Zhu J, Gardell SJ, Livingston JN, Sweet LJ. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology. 2007 Nov;148(11):5175-85. doi: 10.1210/en.2007-0239. Epub 2007 Jul 26. PMID: 17656463.